What is the maximum recommended daily dose of paroxetine for adults, and how does it differ for obsessive‑compulsive disorder, elderly patients, or those with hepatic impairment?

Maximum Dose of Paroxetine

The maximum recommended daily dose of paroxetine is 50 mg/day for most adults, with 60 mg/day used specifically for obsessive-compulsive disorder (OCD), while elderly patients and those with severe hepatic or renal impairment should not exceed 40 mg/day. 1

Standard Adult Dosing

For most psychiatric indications including major depressive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, and PTSD, the maximum dose is 50 mg/day 1, 2. The starting dose is typically 20 mg/day, with increases of 10 mg at weekly intervals if needed.

Obsessive-Compulsive Disorder (OCD)

For OCD specifically, paroxetine can be dosed up to 60 mg/day 1. Clinical trials demonstrated that both 40 mg/day and 60 mg/day doses are significantly more effective than 20 mg/day or placebo for OCD treatment, with mean YBOCS score reductions of approximately 6-7 points at these higher doses compared to only 3-4 points with placebo 1, 3. The 60 mg dose represents the upper limit for this indication and should not be exceeded.

Special Populations Requiring Dose Reduction

Elderly Patients

• Maximum dose: 40 mg/day 1
• Starting dose: 10 mg/day 1
• Plasma concentrations are 70-80% higher in elderly patients compared to younger adults due to altered pharmacokinetics 1

Severe Hepatic Impairment

• Maximum dose: 40 mg/day 1
• Starting dose: 10 mg/day 1
• Patients with hepatic impairment show approximately 2-fold increase in plasma concentrations (AUC, Cmax), with elimination half-life prolonged to 83 hours versus 36 hours in healthy subjects 1, 4

Severe Renal Impairment

• Maximum dose: 40 mg/day 1
• Starting dose: 10 mg/day 1
• Patients with creatinine clearance below 30 mL/min have approximately 4-times greater plasma concentrations than normal volunteers 1
• Those with creatinine clearance 30-60 mL/min show about 2-fold increase in plasma concentrations 1

Critical Pharmacokinetic Considerations

Paroxetine exhibits nonlinear kinetics due to saturation of CYP2D6 metabolism at clinical doses 1. This means that doubling the dose does not simply double the plasma concentration—at 40 mg/day, plasma levels are 2-3 times higher than expected based on linear extrapolation from 20 mg/day 1. This saturable metabolism explains why dose increases must be gradual and why maximum doses are capped.

Common Pitfalls to Avoid

• Do not exceed 60 mg/day under any circumstances, even for treatment-resistant OCD—this is the absolute maximum studied dose 3
• Do not increase doses more frequently than weekly intervals to allow for steady-state achievement given the 21-hour half-life 1
• Do not use standard adult dosing in elderly or hepatically/renally impaired patients without dose reduction—this significantly increases risk of adverse effects and toxicity 1, 4
• Be aware that paroxetine is a potent CYP2D6 inhibitor, which can lead to drug-drug interactions affecting both paroxetine levels and levels of concomitant medications 5, 1